PlainRecalls
FDA Drug Moderate Class II Terminated

Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12

Reported: August 12, 2020 Initiated: July 20, 2020 #D-1446-2020

Product Description

Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12

Reason for Recall

Lack of Assurance of Sterility; potential loose metal overseal crimp defects.

Details

Recalling Firm
Pfizer Inc.
Units Affected
19,144 vials
Distribution
United States including Puerto Rico
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Fentanyl Citrate Inj., USP 100 mcg Fentanyl/2 mL (50 mcg/mL) 2 mL Single-dose Fliptop Vials, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA NDC 0409-9094-12. Recalled by Pfizer Inc.. Units affected: 19,144 vials.
Why was this product recalled?
Lack of Assurance of Sterility; potential loose metal overseal crimp defects.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 12, 2020. Severity: Moderate. Recall number: D-1446-2020.